Оценка эффективности комплексной терапии прогрессирующей глаукомной нейропатии

Аннотация

To evaluate the therapeutic efficacy of gliatilin for stabilizing visual functions after complex treatment of patients with progressive glaucoma-optical neuropathy with "normalized" pressure. Gliatilin is a nootropic drug, a central cholinomimetic with a primary effect on the central nervous system. The inclusion of gliatilin in the complex of therapeutic measures aimed at maintaining visual functions in patients with unstabilized glaucoma, aimed at various links in the pathogenesis ofglaucoma optical neuropathy, makes it possible to achieve stabilization of the process in 89% of patients with far-reaching unstabilized glaucoma for 6 months.